Unchained Labs opens new contract testing facility at its CA headquarters

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/seventyfour)
(Image: Getty/seventyfour)

Related tags: Contract manufacturing, Testing, Lab research, facility, Particle size, Particle size distribution

Unchained Labs’ new facility will support its North American customers with specialized services in particle identification and visibility.

The new contract testing lab is located in Pleasanton, California along with its headquarters.

The company currently has a contract testing lab in Berlin, Germany that supports its European customers. Though Unchained Labs recently closed its other lab in New Jersey, therefore, requiring additional space in North America.

Located in Pleasanton, the new lab, also benefits the contract testing team as its members are now located at the same site as its product development and science teams, according to Taegen Clary, VP of marketing at Unchained Labs.

"The new Pleasanton contract testing lab makes it easier for more customers in North America to take advantage of these services and expands capacity beyond our current test lab in Europe,” ​Clary stated.

The lab will handle the identification of unwanted particles in drug products and quality assessment of silicone layers on drug delivery devices. Additionally, the new space will give the company the capability to take on more projects and provide clients and sponsors with faster results.

“Because we provide specialized services, CROs [contract research organizations] often refer their clients to us if they do not have the tools or expertise to take on these types of projects themselves,”​ Clary told us.

The company stated that two of its instruments are the most often used for contract testing. These instruments include the instrument known as Hound, which determines the count, size, shape, and identity of visible particles with spectroscopy.

Bouncer, the second instrument, can be used to measure the silicone thickness and distribution on syringes, cartridges, and vials for particles in the sub-visible range.

"If someone has particle problems or wants to confirm that the right amount of silicone is on their device, we've got their back,"​ said Clary in a statement.

Related news

Show more

Related products

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us


View more